Comparative phytochemistry and pharmacology of eucommia bark and leaves: implications for sustainable herbal medicine development

Eucommia ulmoides Oliver, a medicinal and edible deciduous tree in China, has long been used in traditional medicine and has been reported to exhibit anti-hypertensive, anti-osteoporotic, hypolipidemic, anti-obesity, and hepatoprotective activities. The bark has traditionally been regarded as the principal medicinal part of Eucommia; however, the slow growth of the tree and the injurious effects of large-scale bark stripping, which may even lead to tree death, have limited the sustainable supply and utilization of Eucommia resources. Eucommia leaves are a renewable resource and contain bioactive constituents similar to those in Eucommia bark, suggesting their potential as an alternative or complementary medicinal resource. This review compares the phytochemical profiles, pharmacological effects, mechanisms of action, and substitution potential of Eucommia bark and leaves. Current evidence indicates that both parts share major bioactive constituents, including iridoids, phenolics, flavonoids, lignans, and terpenoids, and exert beneficial effects on hypertension, osteoporosis, obesity, hyperlipidemia, diabetes, and metabolic dysfunction-associated steatotic liver disease. Their common mechanisms involve regulation of glucose and lipid metabolism, oxidative stress, inflammation, gut microbiota, vascular endothelial function, bone remodeling, hepatic steatosis, and target-organ protection. Nevertheless, the available evidence suggests that bark and leaves differ in their predominant mechanisms of action. Bark-related evidence is stronger for diabetic nephropathy protection, renal fibrosis inhibition, and selected gut microbiota-mediated pathways, whereas leaf-related evidence is stronger for glucose and lipid regulation, adiposity reduction, hepatic steatosis improvement, autophagy–lysosomal lipid clearance, and vascular protection. Overall, Eucommia leaves show promise as a sustainable alternative or complementary resource to bark, providing practical implications for the development of Eucommia-derived functional foods and phytotherapeutic products targeting metabolic disorders. Graphical Abstract: https://links.lww.com/AHM/A251

Authors

Institutions

Publication Details

Journal
Acupuncture and Herbal Medicine
Published
2026-11-20
DOI
https://doi.org/10.1097/hm9.0000000000000218
Primary Topic
Phytochemistry and Biological Activities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative phytochemistry and pharmacology of eucommia bark and leaves: implications for sustainable herbal medicine development

Zhineng Wang, Kuang JiWei, Ying Zhu, Mayu Sun et al.
1 links
Acupuncture and Herbal Medicine
Phytochemistry and Biological Activities
article

Comparative phytochemistry and pharmacology of eucommia bark and leaves: implications for sustainable herbal medicine development

Zhineng Wang, Kuang JiWei, Ying Zhu, Mayu Sun, Ke Xu
article en

Abstract

Eucommia ulmoides Oliver, a medicinal and edible deciduous tree in China, has long been used in traditional medicine and has been reported to exhibit anti-hypertensive, anti-osteoporotic, hypolipidemic, anti-obesity, and hepatoprotective activities. The bark has traditionally been regarded as the principal medicinal part of Eucommia; however, the slow growth of the tree and the injurious effects of large-scale bark stripping, which may even lead to tree death, have limited the sustainable supply and utilization of Eucommia resources. Eucommia leaves are a renewable resource and contain bioactive constituents similar to those in Eucommia bark, suggesting their potential as an alternative or complementary medicinal resource. This review compares the phytochemical profiles, pharmacological effects, mechanisms of action, and substitution potential of Eucommia bark and leaves. Current evidence indicates that both parts share major bioactive constituents, including iridoids, phenolics, flavonoids, lignans, and terpenoids, and exert beneficial effects on hypertension, osteoporosis, obesity, hyperlipidemia, diabetes, and metabolic dysfunction-associated steatotic liver disease. Their common mechanisms involve regulation of glucose and lipid metabolism, oxidative stress, inflammation, gut microbiota, vascular endothelial function, bone remodeling, hepatic steatosis, and target-organ protection. Nevertheless, the available evidence suggests that bark and leaves differ in their predominant mechanisms of action. Bark-related evidence is stronger for diabetic nephropathy protection, renal fibrosis inhibition, and selected gut microbiota-mediated pathways, whereas leaf-related evidence is stronger for glucose and lipid regulation, adiposity reduction, hepatic steatosis improvement, autophagy–lysosomal lipid clearance, and vascular protection. Overall, Eucommia leaves show promise as a sustainable alternative or complementary resource to bark, providing practical implications for the development of Eucommia-derived functional foods and phytotherapeutic products targeting metabolic disorders. Graphical Abstract: https://links.lww.com/AHM/A251

Acupuncture and Herbal Medicine
Qinghai University (CN), Shanghai University of Traditional Chinese Medicine (CN)
Good health and well-being
Phytochemistry and Biological Activities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon